Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India · Delayed Price · Currency is INR 20.91
-0.09 (-0.43%)
Oct 23, 2026, 3:29 PM IST
Balaxi Pharmaceuticals Market Cap
Balaxi Pharmaceuticals has a market cap or net worth of 1.15 billion as of October 23, 2026. It is the 40,261st most valuable company in the world and the 3,186th biggest in India. Its market cap has decreased by 50.43% in one year.
Market Cap
1.15B
Enterprise Value
1.57B
Revenue
2.80B
Global Rank
Country Rank
#3,186 India
PE Ratio
46.77
ChartMarket Cap Chart
Since December 1, 2015, Balaxi Pharmaceuticals's market cap has increased from 41.50M to 1.15B, an increase of 2,681.93%. That is a compound annual growth rate of 35.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 1.15B | -22.18% |
| Dec 31, 2025 | 1.48B | -59.70% |
| Dec 31, 2024 | 3.68B | -16.38% |
| Dec 29, 2023 | 4.40B | -27.68% |
| Dec 30, 2022 | 6.09B | 18.63% |
| Dec 31, 2021 | 5.13B | -21.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bafna Pharmaceuticals | 10.69B |
| Sigachi Industries | 10.06B |
| Valiant Laboratories | 7.12B |
| Amanta Healthcare | 6.14B |
| Nectar Lifesciences | 2.23B |
| Brooks Laboratories | 1.87B |
| Par Drugs and Chemicals | 1.28B |
| Alpa Laboratories | 1.09B |